Correlation Between Dianthus Therapeutics and Emmaus Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Emmaus Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Emmaus Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Emmaus Life Sciences, you can compare the effects of market volatilities on Dianthus Therapeutics and Emmaus Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Emmaus Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Emmaus Life.

Diversification Opportunities for Dianthus Therapeutics and Emmaus Life

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dianthus and Emmaus is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Emmaus Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emmaus Life Sciences and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Emmaus Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emmaus Life Sciences has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Emmaus Life go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Emmaus Life

If you would invest  13.00  in Emmaus Life Sciences on February 1, 2024 and sell it today you would earn a total of  0.00  from holding Emmaus Life Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.35%
ValuesDaily Returns

Dianthus Therapeutics  vs.  Emmaus Life Sciences

 Performance 
       Timeline  
Dianthus Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dianthus Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Dianthus Therapeutics may actually be approaching a critical reversion point that can send shares even higher in June 2024.
Emmaus Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Emmaus Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Emmaus Life is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Dianthus Therapeutics and Emmaus Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dianthus Therapeutics and Emmaus Life

The main advantage of trading using opposite Dianthus Therapeutics and Emmaus Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Emmaus Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will offset losses from the drop in Emmaus Life's long position.
The idea behind Dianthus Therapeutics and Emmaus Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamental Analysis
View fundamental data based on most recent published financial statements